Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
09.05.24
/
50%
€0.40
Target price
09.05.25
€78.88
Performance (%)
1516.16%
End price
10.05.25
-
Summary
This prediction is currently being closed. The BUY prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd. has seen massive gains of 1516.16%. Barclays_PLC has a follow-up prediction for Galmed Pharmaceuticals Ltd. where he still thinks Galmed Pharmaceuticals Ltd. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - |
| iShares Core DAX® | 0,23 % | -2,41 % | 15,34 % |
| iShares Nasdaq 100 | 1,66 % | -1,66 % | 31,09 % |
| iShares Nikkei 225® | -0,21 % | -2,50 % | 43,63 % |
| iShares S&P 500 | 1,07 % | -1,58 % | 24,35 % |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Barclays PLC from $83.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
25.02.26
25.02.26
€104.35
25.02.27
25.02.27
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
10.11.25
10.11.25
€98.63
10.11.26
10.11.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
24.02.25
24.02.25
€98.39
24.02.26
24.02.26
-
25.02.26
25.02.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
08.08.24
08.08.24
€85.19
08.08.25
08.08.25
2270.37%
09.08.25
09.08.25